About: C Nelson Hayes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: C Nelson Hayes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	researcher (en) 연구원 (ko) 研究者 (ja) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh)
rdfs:label	C Nelson Hayes (en) C Nelson Hayes (nl)
skos:prefLabel	C Nelson Hayes (en) C Nelson Hayes (nl)
name	C Nelson Hayes (en) C Nelson Hayes (nl)
instance of	wds:Q87781870-BEEFDCB6-E0B6-447D-846C-E2F1DA2B49D4
instance of	Homo sapiens
ResearchGate profile ID	wds:Q87781870-294c9811-4528-97f7-9434-431ad923dc19
ResearchGate profile ID	C-Nelson-Hayes
Researchmap ID	wds:Q87781870-d72d4d94-40fd-3256-6cae-0afda1865606
Researchmap ID	nelsonhayes4
skos:altLabel	Clair Nelson Hayes (en) Hayes C. Nelson (en) Hayes Clair Nelson (en) Nelson Hayes (en)
occupation	wds:Q87781870-E3CF6691-8BCF-4CD1-AC76-A37CC0956F87
employer	wds:Q87781870-7bf97419-41ba-558a-59fb-c5d603a3bf7b
CiNii Research ID	wds:Q87781870-99954862-8423-417C-B4F1-F53E9359E7DE
sex or gender	wds:Q87781870-c99e97db-4389-7ce6-9172-4394f275cb03
educated at	wds:Q87781870-3f1021bd-4f24-4d38-161e-988e0160c9b3
J-GLOBAL ID	wds:Q87781870-1c8dcc51-46f2-aeac-fa7e-150512d0ad32
CiNii Research ID	https://cir.nii.ac.jp/crid/1420282801187494784.rdf
occupation	researcher
employer	Hiroshima University
CiNii Research ID	1420282801187494784
sex or gender	male
educated at	Pennsylvania State University
J-GLOBAL ID	201801011639497674
ORCID iD	wds:Q87781870-1371FBB8-839B-4251-9A88-B487E927E9F2
ORCID iD	https://orcid.org/0000-0003-1691-3544
ORCID iD	0000-0003-1691-3544
e-Rad researcher number	wds:Q87781870-b61c61a8-453c-13df-d93f-2cb23b9717e0
e-Rad researcher number	50572327
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87781870
is author of	Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle Differences in serum microRNA profiles in hepatitis B and C virus infection. IL28B but not ITPA polymorphism is predictive of response to pegylated interferon, ribavirin, and telaprevir triple therapy in patients with genotype 1 hepatitis C ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients. HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader Assay Hepatitis C virus: How genetic variability affects pathobiology of disease Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A. Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C. Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients. Common genetic polymorphism of ITPA gene affects ribavirin-induced anemia and effect of peg-interferon plus ribavirin therapy. Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1. A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing. Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphism. Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. Genetics of IL28B and HCV--response to infection and treatment HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy Hepatocellular carcinoma: towards personalized medicine. Animal model for study of human hepatitis viruses Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse. Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B. Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C. Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C. Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b. Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report. Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric mice. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial A nonsynonymous polymorphism in semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillation IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. Emerging treatments for chronic hepatitis C. Identification of novel HCV deletion mutants in chronic hepatitis C patients Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction. Pan-genotypic cell culture system for propagation of hepatitis C virus clinical isolates Interleukin-28B polymorphisms and hepatitis C virus clearance.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software